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Endo-parasites that affect humans include Plasmodium, the causative agent of malaria, which remains one of the
leading causes of death in human beings. Despite decades of research, vaccines to this and other endo-parasites
remain elusive. This is in part due to the hyper-variability of the parasites surface proteins. Generally these surface
proteins are encoded by a large family of genes, with only one being dominantly expressed at certain life stages.
Another layer of complexity can be introduced through the alternative splicing of these surface proteins. The
resulting isoforms may differ from each other with regard to cell localisation, substrate affinities and functions. They
may even differ in structure to the extent that they are no longer recognised by the host’s immune system. In many
cases this leads to changes in the N terminus of these proteins. The geographical localisation of endo-parasitic
infections around the tropics and the highest incidences of HIV-1 infection in the same areas, adds a further layer of
complexity as parasitic infections affect the host immune system resulting in higher HIV infection rates, faster
disease progression, and an increase in the severity of infections and complications in HIV diagnosis. This review
discusses some examples of parasite surface proteins that are alternatively spliced in trypanosomes, Plasmodium
and the parasitic worm Schistosoma as well as what role alternate splicing may play in the interaction between HIV
and these endo-parasites.
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Introduction
The expression of genes can be controlled at many levels,
these include transcriptional regulation, post-transcriptional
regulation, translational regulation, mRNA degradation,
protein degradation and through the actions of inhibi-
tory proteins. One of the most important and complex
mechanisms of post-transcriptional control involves al-
ternate selection of splice sites within the pre-mRNA,
which allows multiple different protein products with
different functions to be coded for by a single gene [1].
There are five basic forms of alternative splicing (Figure 1).
These are exon skipping, mutually exclusive exons, alter-
native 5’ or 3’ splice sites and intron retention. Two other
forms of splice variants occur but they are not normally
defined as alternate splicing. These are multiple promoters
and multiple polyadenylation sites [2]. Exon splicing* Correspondence: dlamizl@unisa.ac.za
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distribution, and reproduction in any mediuminvolves the removal or retention of an exon. Mutually
exclusive exons occur when only one of a set of exons is
retained the other is spliced out. Alternative 3’ and 5’
splice sites result in the sequence being extended or
truncated at the 3’ or 5’ end due the occurrence of an
alternate splicing site at either end. Intron retention
occurs when an intron is included and not spliced out
of the transcript. Alternative polyadenylation sites can
shorten the transcript from its 3’ end. Finally, multiple
promoters can lead to transcription starting either up-
stream or downstream of the first promoter creating a
different transcript [2]. RNA splicing is carried out by
the spliceosome, which is a large complex of proteins
that include five small nuclear RNAs (U1, U2, U4, U5
and U6) and over 150 proteins. The association of these
proteins with the snRNAs forms the snRNP (RNA protein
complex). Seven of the associated proteins (SM proteins)
form a ring around a conserved motif on the snRNA.
The pre-mRNA contains short conserved sequences at
the 5’ splice site, 3’ splice site and the branch site which
is located upstream of the 3’ splice site. U1 associatestral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Various forms of alternative splicing. The introns are marked in blue with the exons marked in red, purple, yellow and green as the
sit in order in the gene. (A) Exon skipping occurs when an exon is excluded. (B) Mutually exclusive exons implies that one exon is included while
another is excised (C and D). Alternative splice sites involve the 5’ and 3’ exons being shortened due to internal splice sites. (E) Intron retention
occurs when an intron is retained and not excised. (F) Alternative polyadenylation sites can change the length of the 3’ untranslated region.
(G) Alternate promoters can change transcription initiation sites.
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The tri snRNP complex U4, U5 and U6 then associate
with the pre-mRNA, U1 and U4 are ejected from the
complex and the now activated spliceosome performs
the first step where the branch site of the intron carries
out a nucleophillic attack of the 5’ splice site. The result
is the formation of a lariat structure as the 5’ end of the
intron is bound to the branch site. The second step is
then carried out as the 5’ end of the exon attacks the 3’
splice site resulting in the 5’ and 3’ exons joining. The
lariat is then ejected along with U2, U5 and U6 [3].
In order to survive in the hostile environment pre-
sented by the host organism, parasites have evolved mul-
tiple mechanisms to evade the host’s immune system.
Firstly, the parasites may hide in immune privileged tissue
such as the central nervous system or fat tissue [4,5]. Sec-
ondly parasites can shield surface components to avoid
recognition, which is commonly achieved by binding host
molecules leading to the parasite being recognized as
self by the host immune system [6-8]. Thirdly parasites
may actively interfere with the hosts immune system by
blocking signaling pathways required to activate differentimmune responses [9]. Finally they may change their anti-
genic surface molecules during infection. In order to do
this many parasites have multiple surface variants within
their genomes which are successively expressed [9]. Op-
portunistic infections by parasites in HIV patients are a
common cause of mortality with most of these parasitic
infections being due to protozoan and helminth parasites
[10]. Of particular interest here are protozoan parasites
of the genera Plasmodium, Trypanosoma and helminth
parasites of the genus Schistosoma. The prevalence of
these parasites varies geographically but collectively they
are common in South America, Africa and South East
Asia [10,11]. This coincides with the location of the high-
est prevalence of HIV infection [11,12].
This review will discuss the role that alternative splicing
may play in the ability of a parasite to evade the immune
system of the host. The discovery of alternate splicing giv-
ing rise to different isoforms of antigenic proteins seems
to imply a further means of immune evasion by the para-
site by avoiding immune detection. Some of these alter-
nate splicing events give rise to isoforms with different
functions allowing different interactions between the host
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played by alternative splicing in the interaction between
HIV and parasites.
Alternate splicing in protozoan parasites
Trypanosomes
Trypanosoma is a genus of unicellular, flagellate, protozoan
parasites, which require more than one host to complete
their lifecycle (Figure 2). They are generally transmitted by
blood feeding invertebrates and have a vertebrate host. In
order to penetrate the host’s cells Trypanosoma use mul-
tiple methods including active penetration, active induction
of receptor-mediated phagocytosis, and opsonin-mediated
phagocytosis. Following invasion the parasite causes cells
to rupture releasing trypomastigotes which then multiply.
Trypanosomes belong to the class Kinetoplastida and allFigure 2 The lifecycle of Trypanosoma cruzi and Trypanosoma brucei.
right. The two parasites use different strategies to escape the immune syst
immune system. T. brucei escapes from the immune response by expressin
allowing the parasite to continually evade the host immune system. The p
Antigenic variation most likely evolved to aid in the transmission between
variant surface molecules Variant surface glycoprotiens (VSG) and variant m
mucins and procyclic acidic repertoire protein (PARP).members of this class possess a DNA containing granule
located within their single mitochondrion [13].
Trypanosoma brucei is a uniquely African trypanosome
parasite that causes African sleeping sickness. Nearly 60
million people are at risk from this disease. T. brucei also
causes damage to livestock populations. The parasite is
spread by the tsetse fly Glossina moristans moristans. The
genome of T. brucei is 11 mega bases in size and con-
tains approximately 9000 predicted genes with 900 pseu-
dogenes. Approximately 1700 of these genes are unique to
T. brucei [14]. Studies indicate that on average there are
2.6 splice sites for every gene in T. brucei. The number of
genes with internal splice sites was estimated to be around
488 [15]. Analysis of alternative splicing sites in the gen-
ome of T. brucei pointed to the RNA splicing patterns
changing in the different life stages of the parasite. It wasThe life cycle of T. cruzi is shown on the left, that of T. brucei on the
em of the mammalian host. T. cruzi enters cells to get away from the
g a new VSG. These surface antigens vary after a period of time
arasites are coloured according to the surface antigens they display.
the arthropod and mammalian hosts. Both pathogens express highly
ucins. However, in the arthropod host the parasites express invariant
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the different life stages with regards to: the initiation of
transcription, the rate of mRNA degradation or the recog-
nition of splice sites [15]. It can be concluded that alterna-
tive splicing is required for the development of the
parasite in the different host organisms.
Trypanosoma cruzi is the infectious agent that causes
Chagas disease. This chronic illness is characterized by
cardiomyopathy and the degeneration of the smooth
muscles in the digestive tract. The surface of the parasite
is covered in mucintype O-glycosylated sialoglycoproteins.
These mucin type O-glycosylated proteins are predicted
to play a role in host cell attachment. They also help to
protect the parasite from T cell associated killing. These
molecules are also antigenic and were found to contain
alternate translation start codons preceded by potential
trans-splicing acceptor sites. This could give rise to two
isoforms of protein although the expression of the
smaller variant seems to be dominant [16].
The spliceosome of trypanosomes differs from that of
most eukaryotes due to a less stringent conserved motif
on the snRNA’s SM site. Two Sm proteins (SmB and
SmD3) are replaced by two proteins that are specific to
U2 (SM15K and SM16.5K) (Figure 3). The unique Sm
proteins seem to be an absolute requirement for the
correct assembly of U2 SnRNP, associating with U2 andFigure 3 The spliceosome of Trypanosomes compared to that
of H. sapiens. Unlike the spliceosome of most eukaryotes the SM
protein complex of Trypanosomes contains two unique Sm proteins
SM15K and SM16.5K. The Sm core associates with U2 and not U1 in
Trypanosomes. The human stem loop RNA separating U2A and U1 is
absent in Trypanosomes. The unique SM proteins are required for the
correct assembly of U2A in Trypanosomes. The unique structure of the
Trypanosome spliceosome seems to play a role in Trans-splicing, which
is the dominant form of mRNA splicing in Trypanosomes.not U1 [13,17]. They may also be important for the cor-
rect positioning of mRNA as trypanosomes do not make
use of sequence complementarity to define branch point
sequences [18]. The differences between the structure of
the human and trypanosome spliceosome are not limited
to these Sm proteins, as the human stem loop RNA separ-
ating U2A and U1 is absent in trypanosomes [17]. Genes
in trypanosomes are also arranged in long polycistronic
transcription units. These genes are then transcribed by
RNA polymerase II beginning at switch regions and pro-
ceeding bidirectionally. The resulting RNA undergoes a
specialised form of splicing known as trans-splicing with a
different mRNA transcript [13].
Spliced leader trans-splicing
Another form of splicing known as trans-splicing, is
used to generate a Short Leader sequence of RNA (the
SL RNA), which performs the function of the U1 snRNP
(Figure 4) [13]. As previously stated the Sm core associ-
ates with U2 and not U1 in trypanosomes and knock-
down studies showed that U1 is not required for trans
splicing activities [17,19]. With trans splicing being the
most common form of splicing in trypanosomes, as
most trypanosomal genes do not contain introns, with
only two known examples in T. brucei [17]. Trypano-
somes are able to successfully evade the host’s immune
response by switching the expression of alleles coding
for the Variant Surface Glycoprotein (VSG) [20]. In blood-
stream forms of T. brucei 7-11% of all spliced transcripts
code for VSG [15]. Variations in the surface antigen VSG
are created through spliced leader trans-splicing [21]. This
specific type of mRNA splicing leads to the replacement
of the 5’ end of an mRNA transcript with a small nuclear
mRNA referred to as an SL-RNA. The 3’ end of the trans-
RNA contains a binding site for the Sm protein complex.Figure 4 Spliced Leader RNA trans-splicing. The SL RNA (black)
attaches to the first exon (red) of an mRNA. The outron of the
mRNA and the intron of the SL RNA attach and form a branch in
the same way that in traditional splicing the intron forms a lariat.
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RNAs when the RNA is transcribed by RNA polymerase 1
(Figure 4) [21]. It is also required to turn polycistronic
RNA transcripts into individual monocistronic mRNA
[22]. However, in terms of increasing the hyper variability
of surface proteins of the parasite the most important
role that can be played by SL trans-splicing is that of
“trimming” or “sanitizing” the 5’ untranslated end of
mRNA. By removing the 5’ end of the transcript it does
not matter what sequence is present, and this would
allow for less selective pressure on the 5’ end allowing
for the evolution of the gene, by including new tran-
scription start sites or to incorporate a wider variety of
useful sequence components [22].
The ability to vary the VSG structure and avoid recog-
nition by the host immune system depends on the trans-
splicing of mRNAs encoded by genes that have been
rearranged and duplicated. There are over 1000 VSGs
encoded in the genome of Trypanosomes [23]. This
form of alternative splicing will have important conse-
quences for the cellular location of the peptide as it
changes the N terminal targeting sequence. It may also
play a role in changing the stability and half-life of the
protein.
Plasmodium
For thousands of years malaria has persistently claimed
a large number of human lives. In 1880 a French army
physician, Charles Louis Alphonse Laveran, identified
the causative agent of malaria, in the form of gameto-
cytes of the protozoan parasite Plasmodium falciparum.
The genus Plasmodium is made up of unicellular para-
sites that infect a wide range of hosts. These parasites
replicate asexually and target the host’s erythrocytes
leading to a stiffening of the erythrocyte membrane.
Plasmodium falciparum, as the leading cause of malaria
infection (75% of malaria), is considered the most dan-
gerous parasite. One of the features of malaria is the in-
ability of the host’s immune system to prevent infection
with the re-infection of hosts occurring even in endemic
malaria areas. Malaria parasites are able to evade the im-
mune response of the host, firstly by going through most
of its lifecycle (Figure 5) without presenting any antigen
on the surface of infected cells and secondly by increas-
ing the hyper-variability of the surface proteins. This is
achieved via the amplification of extensive repertoires of
multicopy hyper-variable gene families that encode in-
fected erythrocyte or merozoite surface proteins [24]. The
genome of Plasmodium falciparum consists of roughly
5700 genes and at 19% has the lowest GC content of
any genome sequenced thus far [25]. Sequencing of
RNA transcripts or cDNA libraries pointed to the fact
that the transcriptome contained variable length un-
translated regions as well as prevalent alternate splicingof transcripts [26]. In addition to this over 50% of the
genes in P. falciparum contain introns [27]. Using
current sequencing technologies four types of alternate
splicing strategies were identified in Plasmodium. These
were exon skipping, intron retention or creation and 3’
or 5’ alternate splicing arising from coordinate changes
to exons or alternate start or stop codons [26]. Splicing
of genes in P. falciparum was found to have effects on
the localisation of the protein within the cell as splicing
results in the removal of a signaling peptide. Similarly
the cell localization can be changed by affecting the
solubility of the protein via the removal of a trans-
membrane domain. Splicing has also been observed to
drastically alter protein function due to the removal of
an active domain. Premature stop codon can also con-
tribute to protein regulation by resulting in the abolish-
ment in the expression of the mature protein [28].
Splicing in plasmodium
A putative homolog of the SF2/ASF SR splicing protein
was identified in Plasmodium. This component of the
spliceosome affects alternative splice site selection by
antagonizing other SR proteins as well as functioning to
stimulate transcription by binding to ribosomes [28]. In
addition to this, a functional SR protein PfSR1 as well as
the SR-protein specific kinase that regulates it (PfSRPK1)
have also been identified [29]. The splicing branch
points, that give rise to the excised lariat structure of
the intron, are also unusual in P. falciparum. The 5’
splice site is poorly conserved and is able to still func-
tion with various substitutions. Some introns also have
numerous branch points indicating a further mechanism
for alternate splicing [30].
Alignment of a cDNA library from P. falciparum
revealed that there were 363 splicing events that dem-
onstrated splicing of intron-exon junctions from the
antisense strand. The majority of these antisense tran-
scripts mapped to genes that contain introns, implying
that they may play a role in intron splicing [31]. Anti-
sense splicing may play a role in the control and regu-
lation of transcription of sense RNA. This can be
accomplished through steric hindrance as two poly-
merases cannot function on opposite DNA strands.
An antisense RNA molecule may bind to and hide a
splicing site on the sense mRNA leading to alternate
splicing [31].
Surface antigens
Various antigenic proteins produced by Plasmodium
species are known to have isoforms that are the result of
alternate splicing. The blood antigen protein P41-3 of
P. falciparum is a 375 amino acid protein encoded by a
2137 bp gene. It was the first parasite gene where alterna-
tive splicing was observed (Figure 6) [32]. Alternative
Figure 5 Life cycle of Plasmodium falciparum. The human host harbouring sexually immature parasite is marked using red arrows. Here the
parasite multiplies asexually in the liver (exoerythrocytic schizogony) and in red blood cells (erythrocytic schizogony). The sporozoites that invade
the liver become trophozoites, divide and develop into a liver schizont. These contain thousands of nuclei. The resulting merozoites infect blood
cells and turn into trophozoites. These develop into schizonts with 8–32 nuclei which are released when the erythrocytes burst and can re-infect
new erythrocytes. Erythrocytes that contain other stages stick to the endothelial cells of the blood capillaries, escaping destruction in the spleen,
allowing gametocytes to be produced. The cycle in the mosquito which harbours sexually mature parasites is shown in blue. Here the sexually
differentiated gametocytes change into gametes in the mosquito's gut, where fertilisation of the macrogamete occurs. Large oocysts, containing
up to 10,000 sporozoites, develop on the outer surface of the gut wall. When they burst the sporozoites enter the mosquito's hemolymph, and
ultimately reach the salivary glands.
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scripts of 2.4 kb, 2.1 kb, and 1.4 kb. The exact role of
this protein is not known, however it appears to be a
soluble protein that is exported from the parasite [32].
The P. falciparum surface antigen UB05, which is rec-
ognized by IgG antibodies from adults that are semi-
immune to malaria infection [33], was found to be
alternatively spliced through 3’ and 5’ alternate spli-
cing [26,34]. Another suspected surface antigen, PF
70, is soluble in Triton X, suggesting that it is membrane
bound. The protein is a novel 70 kDa protein that reacts
with anti P. falciparum and anti P. yoelli serum [35].
The mRNA coding for PF 70 contains a 5’ alternative
splice site, resulting in a protein that is 25 amino acids
shorter than the protein translated from the full length
transcript [34].Another class of surface antigens, Merozoite Surface
Proteins (MSP) are proteins found on the surface of
protozoan daughter cells. Interest has been expressed in
the use of these proteins to create a malaria vaccine, as
initial reports suggested that this protein is exposed on
the surface of the merozoite and displays limited genetic
diversity [36]. In P. falciparum chromosome 2 contains
three MSPs: MSP2, MSP4 and MSP5. MSP5 is a 40 kDa
glycosylphosphatidylinositol (GPI)-anchored protein with
an epidermal growth factor domain [37]. However, re-
cently it was discovered that MSP5 is alternatively
spliced using an alternate stop codon (Figure 6) [26].
This may then result in increased variation despite a
high sequence similarity, thus allowing the merozoite to
avoid the immune system of the host and decreasing its
usefulness as a vaccine target.
Figure 6 Transcripts of alternatively spliced immune related genes in Plasmodium. (A) The blood antigen protein P41-3 is alternatively
spliced to give rise to three different transcripts of 2.4 kb, 2.1 kb, and 1.4 kb. (B) The MAEBL trans-membrane receptor binds erythrocytes and is
expressed as different isoforms depending on the developmental stage of the parasite. The maebl gene consists of two open reading frames
ORF1 and ORF2. Some of the isoforms are soluble unlike the typical trans-membrane MAEBL and these soluble isoforms are the result of an ORF2
transcript. (C) Merozoite surface proteins found on the surface of the merozoite P. falciparum contain three MSPs: MSP2, MSP4 and MSP5. The
40 kDa MSP5 is alternatively spliced using an alternate stop codon.
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erythrocytes to the endothelial lining of blood vessels
[38]. The Merozoite Apical Erythrocyte-Binding Ligand
(MAEBL) trans-membrane receptor was identified in the
blood stage of P. falciparum. The protein binds erythro-
cytes and unlike many proteins from P. falciparum,
which seem to be stage specific, MAEBL is expressed in
both sporozoites and merozoites. However, the maebl
gene consists of two open reading frames ORF1 and
ORF2. This results in maebl being expressed as different
isoforms depending on the developmental stage of the
parasite (Figure 6) [39]. Some of the isoforms are soluble
unlike the typical trans-membrane MAEBL and these
soluble isoforms are the result of an ORF2 transcript.
Transcripts of this soluble MAEBL are only found in the
oocyst stage. It is unknown what the significance of
these alternatively spliced isoforms are [39]. Another
protein involved in erythrocyte binding is Cytoadherence
linked asexual gene 9 (clag9). This is a trans-membrane
protein found on the surface of infected erythrocytes
that is required to bind to the endothelial cell receptors
[40]. By measuring antibody response to synthetic clag9,
it was determined that this protein is immunogenic [41].
Clag9 was found to be alternatively spliced through 3’
and 5’ alternative splicing [26]. The exact roles played by
the isoforms of these various protein antigens remains
unknown.
In addition to these Otto [26] concluded that there
were an additional 32 conserved unidentified proteins in
P. falciparum that could be expressed as different isoforms
due to alternate splicing. Another member of the phylum
Apicomplexa that is closely related to Plasmodium isTheileria annulata. Theileria are able to reversibly trans-
form their host’s cells. These parasites are tick borne and
cause lympho-proliferative diseases of cattle – tropical
theileriosis and East Coast fever (ECF) [42]. The gene cod-
ing for an immunogenic protein, that was used to establish
a diagnostic ELISA assay, was given the name clone 5.
This gene is alternately spliced at its single intron. This
splicing is a combination of intron retention and 3’ splice
site alteration due to the introduction of another stop
codon. Both mRNAs are translated into a corresponding
long and short protein [43].
Hyper-variable gene families
Plasmodium species express four families of hyper-variable
genes. These genes have many copies in the genome. The
first of these families is used to prevent the parasite being
sent through the spleen and destroyed. The P. falciparum
erythrocyte membrane protein 1 (PfEMP1) family, are
large proteins ranging between 250 and 300 kDa. They
function as cytoadhesion proteins which results in infected
erythrocytes sticking to the walls of blood vessels and not
cycling through the spleen. These proteins are encoded by
a multicopy gene family named var which consists of
about 60 genes, of these only a single protein is expressed
at a time leading to a wide variety of antigenic phenotypes
and cyto-adherent abilities [24]. The Plasmodium vivax
homologs of the var family, named the vir family, display
varying numbers of exons as well as alternate splicing
[44]. Var gene expression seems to be regulated through
chromatin remodeling as var expression is silenced by his-
tone deacetylases and enhanced by histone acetylation
[45]. Two separate promoters control var gene expression.
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ternal intron promoter which creates a non-coding RNA.
The intron promoter seems to be bi-directional. This pro-
moter gives rise to short antisense mRNA that appears to
associate with the var genes on the chromosome. In this
way the antisense RNA may regulate the transcription of
var gene products [45].
The other three families all contain a trafficking motif
known as pexel/TS, which allows the protein to be trans-
ported to the cytoplasm of the infected erythrocyte. They
also share the same gene architecture consisting of a short
first exon encoding a signal peptide followed by a longer
exon. All three families code for trans-membrane proteins
of varying size but similar structure. They consist of a two
trans-membrane domains joined by a variable loop. This
loop contains the hypervariable region which is exposed
on the outside of the erythrocyte to antibody mediated
immune selection [24]. The Pfmc-2TM family consists
of 13 genes; the subtelomeric variable open reading
frame family (stevor) consists of 30–40 genes [24] and
the repetitive interspersed family (rif ) consists of over
150 copies. This makes the Rif family the largest gene
family in P. falciparum [46]. There is evidence that both
the rif and stevor genes are alternatively spliced.
Stevor is suspected to play a role in antigenic variation
[47,48]. It is expressed in the late stages of the asexual
forms of the parasite, where it gathers in structures
known as the Maurer’s cleft. This structure plays a role
in the release of parasites from erythrocytes [48]. The
expression of the protein at only the late stages seems to
imply that it plays a role in the release of the parasite
from erythrocytes or alternatively it acts to shield other
cleft components from the immune system of the host
[48]. Stevor is also expressed in the gametocytes and it is
here where alternate splicing gives rise to a truncated
version that lacks one of the trans-membrane regions
[48], implying changes in the proteins function of local-
isation. These Stevor transcripts have a diverse structure
resulting from the use of alternate splice sites giving rise
to frame shifts and deletions [49]. Mature stage gameto-
cyte infected erythrocytes need to re-enter circulationFigure 7 Alternative splicing of the Anopheles gambiae Down syndrom
multiple alternative splice exons within its IG regions. The above image sho
encoding these domains. Exons 4, 6, 10 and 14 are alternately spliced with
combinations of these exons can give rise to 31 920 splice forms. The prot
isoforms allowing it to recognize, bind and respond to a wide array of diffein order to infect blood feeding mosquitoes. This is
achieved by increasing the severity of membrane deform-
ation. Stevor has been shown to play a role in erythrocyte
membrane deformation [50] where an increase in the rate
of disassociation of Stevor from the membrane surface
occurs prior to increased membrane deformation [51]. A
switch between the transcription of various isoforms, es-
pecially those with fewer trans-membrane regions, may
aid in this dissociation. The Rif family was found to be 3’
and 5’ alternately spliced [26]. The ORF of the genes are
also spliced into short signaling peptides [46].
Alternative splicing of genes in the immune response of the
mosquito host
The salivary gland of the female mosquito is the primary
site of infection by Plasmodium parasites. An analysis of
the transcriptome of the salivary gland before and after
infection revealed changes in the levels and identities of
the transcripts. In the case of the D7 odorant binding
protein (OBP) there is a change in the identity of the
transcripts due to alternate splicing [52]. There are in-
stances in which odorant receptor molecules have been
identified as being involved in innate immune signalling
systems [53]. Additionally expression of OBPs may be in
response to oxidative stress where they act as scavengers
of reactive oxygen species [54] and this may be import-
ant to protect the mosquito from the negative effects of
its own immune response to the parasite. Infection with
dengue virus increased the expression of OBP in Aedes
aegypti. This was shown to be a strategy by the virus to
manipulate the behavior of the mosquito with an increase
in the expression of OBPs leading to an increase in the
frequency of the mosquito feeding, thereby increasing
host infection [55].
Molecules with a more direct function in the immune
system whose transcription is altered following infection
with malaria parasites include serpins [56], peptidogly-
can recognition proteins [57] and Down syndrome cell
adhesion molecule (Figure 7) [58]. Serpins play an im-
portant role in the regulation of the immune response.
The classic example is the role played by the serpin Nece cell adhesion molecule (DSCAM). This Ig domain protein has
ws the different domains found within the protein and the exons
14, 16, 38 and 2 alternate exons respectively. The different
ein plays a pathogen recognition role, with the large number of
rent pathogens.
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serine protease Persephone [59]. As a result of alternate
splicing the Serpin10 gene of Anopheles gambiae can
give rise to four splice variants due to alternate splicing.
The transcription of two of these isoforms is increased
following infection with Plasmodium bergii while bac-
terial infection had a different effect on the levels of
each isoforms mRNA [56]. Serpin10 is also known as
plasmodium-related inhibitory serine protease inhibitor
[60]. Alternative splicing also gives rise to three isoforms
of Serpin4 from A. gambiae [61]. The functional role of
these isoforms is unknown. However, the A. gambiae
Serpin10 and Serpin4 show the highest sequence simi-
larity with the Drosophila melanogaster Serpin42Da and
Serpin28Dc respectively. Serpin28Dc is suspected to play a
negative role in the regulation of melanization, the defense
response and to be involved in the wound response [62].
An A. gambiae a homolog of the Peptidoglycan Rec-
ognition Protein long form C was found to encode for
three different isoforms which carry alternative PGRP
domains linked to a common backbone consisting of a
trans-membrane region and signaling peptide [57]. In
Drosophila this protein is required for the detection of
bacterial pathogens and initiates an immune response via
the Imd pathway [63]. The mosquito isoforms are, how-
ever, differentially transcribed depending on the nature of
the infectious agent [57]. The mosquito PGRP-LC detects
bacterial infection but also detects Plasmodium and this
detection results in an anti-parasitic defense response. The
isoform responsible for this detection and subsequent
response is PGRP-LC3 [64].
The Down syndrome cell adhesion molecule (DSCAM)
is an Ig domain containing protein that was identified in
Drosophila as playing a role in neuronal guidance. This
molecule contains multiple alternative splice exons within
its IG regions (84) that can give rise to 31 920 splice forms
(Figure 7) [58,65]. It was first suspected to be involved in
the immune response of insects when it was found to be
expressed in immune related cells within Drosophila and
was later identified to be an essential recognition molecule
in the insects immune response [65]. The hyper variability
of the molecule allows it to recognize, bind and respond
to a wide array of different pathogens with differently
spliced forms being expressed in response to different
pathogens [58,65]. Plasmodium infection results in the in-
crease in variability of exon 4 and 6 in particular. The in-
crease in the variability of exon 6 also seems indicative of
infection by multiple strains of Plasmodium with different
genotypes [58]. In this way the mosquito can respond to
the hyper variability of the pathogen.
Schistosoma
The tropical disease schistosomiasis is caused by blood
flukes of the genus Schistosoma. This disease affects210 million people and is still a major source of mor-
bidity, causing approximately 280, 000 deaths per year
in sub-Saharan Africa. These worms require a verte-
brate host and an intermediate gastropod host (Figure 8).
Schistosomes are not hermaphroditic with male worms
having a gynecophoral canal in which the female worm
resides. The sequencing of the genome of Schistosoma
mansoni revealed 11, 809 putative genes encoding 13,197
transcripts [66].
The first report of alternate splicing in S. mansoni
concerned the use of sera from humans infected with S.
mansoni to recognise an antigen from esophageal gland
of S. mansoni. This antigen was given the name 10–3
and is made up of multiple alternatively spliced 27 bp
exons and 81 bp repeats [67]. Alternative splicing also oc-
curs due to different transcription start sites and changes
in mRNA processing. This alternative splicing gives rise to
isoforms that are differentially expressed in different life
stages of the parasite (Figure 9). The 10–3 gene contains
tandem repeats and all transcripts share the same 3’ se-
quence. However, the sequence 5’ of the tandem repeats is
variable [68].
At least 45 genes were identified that contained a gene
structure consisting of multiple very small exons (micro-
exon structure) (Figure 9). Although micro-exon genes
(MEG) have been identified in other organisms, S. mansoni
is unusual in that the micro exons can make up to 75%
of the coding sequence of the gene. Most of these genes
contain a signal peptide at the 5’ end, while three have
membrane anchors. Sequencing of transcripts of MEGs
from families MEG-1, MEG-2 and MEG-3 showed that
there were up to seven splice variants that arose due to
exon skipping [66,67]. The 10–3 antigen described
above was identified as a MEG and given the alternate
name of MEG-4 [67]. The initial number of micro exon
containing genes (45) that were identified in S. mansoni
[66] was upon further analysis expanded by another 27
genes giving a total of 72 genes consisting of microex-
ons. These genes can be divided into 18 families, which
can be further divided into two groups, based on the
number of members they contain [67]. Further tran-
scriptome sequencing may have identified a further 11
micro-exon containing genes [69]. Protein expression
studies show these genes code for small proteins with
isoforms that have very similar size and charge that appear
to be secreted. These proteins are expressed in epithelial
and gland tissue. 16 MEG protein products have also
been detected in secretions or detected in the glands of
S. mansoni. The transcription of these genes increases
during the mammalian stages of the life cycle where the
parasite may interact with the host’s immune system,
and appear to be associated with host invasion and persist-
ence within the host [67,70]. Another feature of MEGs
which allows for the neat segmentation of the coding
Figure 8 Life cycle of Schistosomes. Unlike other Trematodes, schistosome adults have two sexes and are located in blood vessels. Eggs from
human hosts hatch into free swimming miracidia which infect specific snail species. These develop into two generations of sporocysts and result
in the production of cercariae which are released from the snail and swim freely in water where they encounter and penetrate the skin of the
human host. The cercariae shed their tails to become schistosomules, which enter small veins and develop into adult worms in mesenteric veins.
Their exact location varies with species. S. hematobium occurs in the bladder venous plexus and rectal veins. Eggs are deposited in the small
veins of the portal and perivesical systems. In S. mansoni (pink arrows) and S. japonicum (green arrows) the eggs migrate to the lumen of the
intestine and are excreted in the feces. In S. hematobium (black arrows) eggs migrate towards the lumen of the intestine or the bladder and
uterus and are eliminated with feces or urine.
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allows for the excision and without altering the reading
frame [67].
Despite the fact that some of these proteins may be
membrane bound and therefore exposed to the external
environment of the host; it is unknown whether they are
antigens. However, as they are detected in secretions
and seem to be directly associated with a particular life
stage, it is likely that these proteins are being directly ex-
posed to the host and its immune system [67]. Therefore,
the ability to vary their structure may provide protection
against immune recognition by the host through an anti-
genic variation based immune evasion strategy similar to
that seen in trypanosomes and Plasmodium. However un-
like the antigenic variation genes within those parasites,these MEGs are expressed simultaneously and not sequen-
tially [67]. A gender based alternative splicing of a tran-
scription co-factor that interacts with the spliceosome was
identified in S. mansoni. The gene SmCA150 codes for a
protein that influences the alternative splicing of other
gene transcripts. This may form the basis for other differ-
ences observed in RNA splicing observed between males
and females [71].
The S. mansoni venom allergen like (SmVAL) protein
family was given this name due to the similarity of the
proteins with wasp venom allergen [72]. All these proteins
contain a sperm coating protein domain. This domain is
found in proteins that play a role in the immune response,
testes development, as a venom toxin and host invasion,
where parasitic nematode species secrete SCP/TAPS
Figure 9 (See legend on next page.)
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Figure 9 Transcripts of alternatively spliced immune related genes in Schistosoma mansoni. (A) MEG 1 has 18 isoforms. These isoforms
display very lifestage specific transcription. The exact role of MEG1 is unknown. (B) MEG 3 has four members with three, 10, three, and two
isoforms four family members with 3, 1 and 4 isoforms each. MEG 3 is also known as GRAIL. (C) The 10–3 surface antigen also known as MEG 4
has different transcription start sites that give rise to two isoforms that are expressed at different stages in the parasites lifecycle. (D) SmVAL6
contains 38 exons, the four largest code for conserved protein motifs, while the smaller exons are alternately spliced to give rise to at least 5
isoforms. SmVAL6 probably arose due to a recombination event between a MEG gene and a SmVAL gene.
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proteins containing this domain are involved in the im-
mune response, while in mammals they are known to
be involved in lung development [73].
29 SmVAL genes have been identified and can be di-
vided into two groups. The first group codes for proteins
that contain a signal peptide and appear to be excreted.
The second group codes for proteins that do not contain
a signal peptide and should play an intracellular role
[72]. Group 1 VALs such as 1, 2, 3, 4, 5, 7, 8, 9, 10, 12,
14, 15, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27 and 28) are
associated with host invasion. SmVALs4 10 and 18 are
associated with the invasion of the mammalian host.
The other group 1 VALs appear to be involved with the
invasion of the molluscan host. The role of most group
two SmVALs such 6, 11, 13, 16 and 17 are unknown.
However SmVAL6 is a group 2 VAL expressed during
the mammalian life stages [73]. The presence of VALs in
parasitic and non-parasitic helminthes indicates that
they may play a role in life cycle changes [73].
Through the use of Rapid Amplification of cDNA Ends
(RACE) mRNA isoforms were identified for multiple
SmVALs. These included SmVAL1, SmVAL2, SmVAL4,
SmVAL6, SmVAL7 and SmVAL11 [72]. SmVAL6 was
shown to contain micro-exons with alternative use of
these exons giving rise to the different isoforms [72].
These isoforms were expressed at different lifestages
of the parasite. For instance SmVAL1, SmVAL2 and
SmVAL4 isoforms were isolated from mixed sex cercariae
RNA while SmVAL6, SmVAL7 and SmVAL11 isoforms
were isolated from mixed sex, 7-week adult RNA [72].
One of the members of this family SmVAL6 contains four
exons of an average size and code for the conserved motifs
in the protein family (Figure 9). However, this is followed
by seven small exons, which is similar to the structure of
MEGs. As many as 5 isoforms have been identified that
occur due to alternate splicing of these smaller exons.
SmVAL6 probably arose due to a recombination event be-
tween a MEG gene and a SmVAL gene. Additionally, both
proteins are excreted and therefore will probably interact
with the host’s immune system and generate an immune
response [72]. The antigenic role played by different
SmVALs was found to vary amongst individual family
members. For example despite SmVAL4 and SmVAL26
both being secreted group 1 VALs, SmVal4 elicits an
immune response in mice while smVAL26 does not, asassessed by a mouse model of airway inflammation.
This difference in members of this family to elicit an
immune response is most likely based on the localisa-
tion of the protein within the parasite. SmVAL4 and
SmVAL26 are both group 1 SmVALs and are secreted.
Transcription and expression data show that SmVAL4
is excreted during mammalian host skin invasion and is
released during the cercariae stage, while SmVAL26 is
excreted from the egg (Figure 8) [74].
The polymorphic mucins (SmPoMucs) are a protein
family consisting of approximately ten members in S
mansoni. The gene structure consists of between 0 and
20 tandem repeats of a 27 base pair exon near to the 5’
end of the genes. Alternative splicing as well as trans-
splicing between transcripts generates hyper variability.
Splicing also affects the proteins post-translational modi-
fication [75]. The mollusc host produces a highly vari-
able immune receptor Fibrinogen Related Protein 3
(FREP3) that is required for host resistance to infection
by S. mansoni [76,77]. These FREP3s interact and form
complexes with the SmPoMucs [76]. Therefore the vari-
ation produced by alternate splicing plays a role in avoid-
ing recognition by the invertebrate host’s immune system.
Parasites, host immunity and HIV
Like the immune response against most infectious agents,
the immune response to parasites includes non-specific
factors, such as the genetic factors of the host, and specific
immune responses. Cellular immunity appears to be the
most important immune response against parasites such
as Plasmodium while antibody based responses are the
most important when dealing with trypanosomes. Cyto-
kine production by the different subsets of T cells is im-
portant in the immune response and patient pathology
[78]. Different subsets of helper and cytotoxic T cells are
activated in response to different parasite infections. The
Th1 cells respond through the production of interferon
(IFN)-interleukin (IL)-12 and results in the activation of
monocytes and macrophages and CD8+ cytotoxic cells.
The Th2 cells produce IL-4, IL-5, IL-13 and results in anti-
body production [79].
The ideal situation for these eukaryotic parasites is to
exist in the host at a level where infection persists without
resulting in the death of the host. This chronic infection
will result in a high incidence of immunopathology [78].
Patients with an immunocompromised immune system
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or HIV infection show impaired CD4+ cell mediated im-
mune response and an exacerbation of disease associated
pathology [79]. Due to the overlap in the geographical
locations of the highest incidence of HIV and most of the
protozoan parasite infections (Figure 10), the combined
effect of parasitic and HIV infections has proved to be
an important consideration for diagnosis, treatment and
prognosis of these infections.
Infections with trypanosomes [80], malaria [81] and
Schistosoma [82] are known to complicate the diagnosis
of HIV infection using rapid diagnostic tests, due to the
parasites inducing polyclonal B cell activation. This results
in the production of a wide array of non-specific anti-
bodies that can result in false positive diagnoses [80].
Chronic malaria infection also results in the increase in
the levels of HIV RNA as well as a decrease in CD4+ cell
number while HIV infection results in the increase in the
severity of bouts of malaria [83]. Schistosoma infections
accelerate HIV disease progression and transmission. This
is largely due to physical damage in the urinary tract of
the host as a result of the presence of the parasites eggs
[12]. Schistosoma co-infection of Rhesus Macaques in-
fected with Chronic Simian-Human Immunodeficiency
Virus Clade C led to an increase in viral RNA expressionFigure 10 The overlap in the geographical location of high HIV preve
Africa show the prevelance of HIV infection (A) and the occurrence of the
Plasmodium species (C) and Schistosoma parasites (D). These maps demon
This implies that the increase in HIV prevelance observed in these areas maand lower CD4+ counts [84]. S. mansoni infection leads
to the increase in the number of cytokines cell surface
receptors which can be used by HIV to infect a cell. The
parasite also suppresses the Th1 immune response
needed for the immune response to HIV [12,85]. For in-
stance Schistosoma infection leads to increased CXCR4
expression levels on individual cells, but does not in-
crease the number of cells that express this receptor.
However, treatment of schistosomiasis leads to a decrease
in the level of CCR5 and CXCR4 on CD4+ cells in both
HIV infected and uninfected patients. Schistosomiasis was
also found to lead to increased susceptibility to HIV infec-
tion, while treatment decreases the susceptibility to HIV
infection and may slow disease progression [85]. Infection
with T. brucei prior to HIV infection can however, de-
crease the viral infectivity, by inhibiting the ability of the
virus from entering cells [86]. These interactions between
parasites and HIV that alter infectivity and lowers the
prognosis for AIDS appear to occur mainly at the level of
the cell signaling molecules and cytokines. This may be
due to the increase in the levels of cytokines such as
(IFN)-γ, interleukin (IL)-12 and TNF, which can stimulate
HIV replication [83], the inhibition of IL-2 synthesis
[87] increase in CCR5 and CXCR4 synthesis [12]. Many
of these cytokines, such as CD4, CD8 and CTLA4, arelance and parasitic diseases. The above maps of South America and
parasitic infections by T. cruzi and T. brucei (B); malaria causing
strate that there is a geographical overlap amongst these infection.
y partly be due to the effect these paerasites have on host immunity.
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splicing patterns for these genes changing in response
to antigen levels (Figure 11) [88].
CD45
At least 5 different CD45 isoforms are expressed due to
the alternate splicing of introns 4–6. These isoforms
range in size from about 180–240 kDa (Figure 11) with
the levels of the lower molecular weight isoforms in-
creasing after the T cell has been exposed to an antigen.
These T cells with higher levels of the low molecular
weight forms also have a higher turnover rate [89,90].
These CD45 isoforms may also differ in their ability to
promote IL-2 secretion, their ability to associate with
CD4 and CD8 and their ability to promote B cell matur-
ation. Evidence does exist for the homodimerisation of
CD45 which may also regulate CD45 function further
through the homodimerisation of different isoforms
[90]. It has also been noted that the expression of these
isoforms may be dependent on the type of cell or the
state of cell activation and differentiation [91], while
HIV infection results in reduced surface expression of
all CD45 isoforms [92].
The T. evansi parasite that causes surra disease in
animals possesses a membrane bound toxic protein that
kills lymphocytes in a CD45 dependent manner. The pres-
ence of CD45 isoforms may explain why only some of theFigure 11 Alternative splicing of cell surface receptors in Homo sapie
data was available to construct a diagram showing splicing for 4 CD45 isof
The resulting mRNAs differ drastically in size and sequence. The CD45 gene
Isoforms 1 and 2 contain multiple exons dispersed across a large 60 kbp st
transcript derived from an alternative upstream promoter. The larger isofor
CXCR3 isoforms have been identified which interact with the same chemo
isoform present.population of peripheral blood mononuclear cell (PBMCs)
died after they were treated with T. evansi protein extracts
[91]. Like HIV, trypanosome parasites are further able to
suppress the immune system of their mammalian hosts
via an increase in the apoptotic killing of T cells [87]. In-
fection with trypanosome parasites induces a strong CD8+
T cell response in mammalian hosts. These cells predom-
inantly recognise the trans-sialdase epitope [93]. T. cruzi
and T. brucei do not synthesize their own sialic acid for
inclusion into their surface receptors. Instead they make
use of the enzyme Trans-Sialidase found on the surface
of the parasites, to transfer sialic residues from the
sialic-glycosylates of the host. This enzyme is also shed
into the bloodstream where it leads to the induction of
apoptosis in immune related cells [94]. This is a result
of the sialylation of surface receptors such as CD4, CD8
and CD45 [94,95]. The different isoforms of CD45 are
the main targets of Trans Sialidase, which may result in
changes to the functions of the different isoforms due to
changes in glycosylation [94].
Chronic P. falciparum exposure results in atypical
memory B cells (MBC) that express increased levels of
CD45RA as well as negative regulators of T cell response
Programmed Death 1 (PD-1) and lymphocyte-activation
gene-3 (LAG-3) [96]. Atypical MBCs are also a charac-
teristic of HIV infection. These MBCs are less respon-
sive to infection and are thus known as exhausted CD8+ns that play a role in HIV and parasite infections. (A) Sequence
orms. These isoforms arise due to the alternate splicing of introns 4–6.
is 125 kbp in size with a large intron between exons 2 and 3.
retch of DNA. (B) Two CCR5 arise due to alternative splicing of a
m negatively controls the expression of the smaller isoform. (C) Two
kines but, this interaction results in opposing signaling based on the
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CD45-RA [98] and this combined with the expression of
the negative regulators of T-cell activation, suggests
another means for P. falciparum to evade the immune
response of the host.
CCR5
The chemokine receptor CCR5 found on the surface of
white blood cells plays a central role in HIV infection,
where it acts as a co-receptor allowing the virus to enter
target cells. Multiple isoforms of CCR5 arise due to al-
ternative promoter regions as well as mRNA splicing
(Figure 11). Of particular interest is two isoforms that
arise due to the alternative splicing of a transcript de-
rived from an upstream promoter [99]. Studies indicated
that the longer isoform plays a role in negatively regulat-
ing the expression of the shorter isoform. Further iso-
forms that arise due to processing of transcripts from a
downstream promoter may also play a role in expression
by changing the stability of the mRNA [99]. HIV is too
recent a human pathogen to have exerted any selective
pressure on the various isoforms. However, pathogens
that have infected humans for longer may have played
an important role in exerting a selective pressure on the
function and occurrence of these regulatory isoforms
[100]. CCR5 isoforms that are unstable or down regulate
the expression of active CCR5, result in an increased re-
sistance to HIV and Plasmodium vivax infection [101].
CCR5 expression levels also influences the expression
of IL-2 as well as the development of mature memory
T-cells. These cells have higher levels of IL-2 and dis-
play an increased susceptibility to HIV infectivity [102].
Chronic T. cruzi infection, resulting in chronic Chagas
disease can lead to cardiomyopathy due to the immune
response damaging the tissues of the heart. This cardio-
myopathy is accompanied by an increase in the expression
of CCR5 on the surface of circulating lymphocytes and
the use of a partial CCR5 antagonist protected mice
from cardiomyopathy [103]. However, T. brucei infec-
tions can inhibit the entry of HIV into monocyte derived
macrophages (MDM) partly due to a decrease in the ex-
pression of CCR5 [86]. Treatment of schistosomiasis leads
to a decrease in the level of CCR5 and CXCR4 on CD4+
cells in both HIV infected and uninfected patients [85].
CXCR3
Expression of the chemokine CXCR3 is increased follow-
ing Schistosoma infection. CXCR3 is primarily expressed
on NK cells and activated T lymphocytes. Two isoforms
of CXCR3, generated by alternative splicing (Figure 11),
allow many of the chemokines known to interact with
CXCR3 (CXCL-9, CXCL10 and CXCL11) to play oppos-
ing roles when it comes to cell proliferation. The ori-
ginal isoform named CXCR3-A results in an increase incell proliferation while CXCR3-B increases apoptosis
levels. CXCR3 expression and function is up-regulated
following Schistosoma infection [104] while mice lacking
active CXCR3 showed an increased pathology associated
with Leishmania major infection [105].
Cerebral malaria is a form of encephalopathy that results
from the introduction of inflammatory molecules into the
Central Nervous System via a damaged blood brain barrier
(BBB). Damage to the BBB is caused by the adherence of
parasitised red blood cells to the endothelial layer of
the barrier [106]. Studies using CXCR3 knockout mice
have demonstrated that this damage is mediated by
CD8+ T cells which are recruited by CXCR3, and CXCR3-
mice fail to develop cerebral malaria [107,108]. The CXCR3
ligands CXCL9 and CXCL10 are also required for the
development of cerebral malaria [108], but they are
expressed in a tissue dependent manner with microglia
having increased levels of CXCL9 and astrocytes having
increased levels of CXCL10, while the levels of both
were elevated in neurons [107,108]. A similar situation
was observed following the intracranial infection of
mice with Toxoplasma gondii. Here two populations of
microglia formed in response to the infection, one con-
taining the endotoxin response protein immunorespon-
sive gene 1 (IRG1) and CCR9; the other lacks IRG but
expresses CXCR3. The IRG1+/CCR9+ microglia is neuro-
toxic and resistant to apoptosis while the IRG-/CXCR3+
microglia are neuro-supportive and sensitive to apoptosis
[109]. The chronic activation of microglia in response to
infection appears to be responsible for the neurodegenera-
tion observed during AIDS. HIV targets microglia, which
appear to be the only cells in the CNS which are product-
ively infected with the virus, infected microglia then re-
lease neurotoxin mediators that result in the death of
neurons and encephalopathy [110,111]. Low infection
rates are observed in astrocytes and these may play the
role of viral reservoirs [111]. The different roles played by
CXCR3 in different infection and different stages of the
infections may be governed by the various expression of
one of the two isoforms. This would change the sensitivity
of the cells to apoptotic stimuli and would allow the
microglia to survive and act as a viral reservoir in HIV as
well as allowing varied responses to different cytokines
during the progression of cerebral malaria.
Conclusion
Despite decades of research there is currently no vaccine
to any human parasite. One of the major reasons why
vaccines seem to fail during phase II trials is the diver-
sity of the parasite. Not only does the hypervariability of
surface proteins make it difficult to target, but parasites
can also show the ability to rapidly develop drug resist-
ance due to rapid evolution. Immune evasion of parasites
through antigenic variation is a complex process with a
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majority of studies and reviews examine antigenic vari-
ation through the expression of different members of a
multigene family and not through the alternate splicing of
mRNA. The control of RNA transcription is poorly under-
stood within Trypanosoma and Plasmodium. With the
genomic sequences of these parasites and a better under-
standing of the role played by Trans SL RNA splicing and
transcriptional control through antisense RNA, we are
gaining a better picture of gene regulation in these para-
sites. It is important to understand the role played by the
expression of different isoforms of antigens in immune
evasion as these isoforms may offer new targets for ther-
apy. This would involve the preferential selection of one
isoform over another. This could be beneficial by leading
to a either a decrease in immune evasion or a decrease in
parasite viability. As many isoforms are expressed in a life
stage specific manner, the expression of unique sets of
genes at different life stages of the parasite points to a use-
ful strategy involving the targeting of one of these particu-
lar stages, interfering in the progression from one life
stage into another. Alternatively the life stage expression
of different isoforms could be used as a diagnostic tool.
The geographical co-localisation of parasite infections
by members of the genera Plasmodium, Schistosoma and
Trypanosoma with a high prevalence of HIV infection,
suggests that infection with parasites contributes to HIV
infection and disease progression. HIV and parasite infec-
tion both lead to a suppression of the cellular immune sys-
tem. These pathogens interact with the cellular immune
system at the level of cell surface receptors and cytokines.
The alternate splicing of the transcripts for these genes
leads to drastic changes in their regulation and function.
This may alter the way that parasites and HIV interact
with the host’s immune system and with each other at a
molecular level. Once again the preferential expression of
some isoforms over others may have therapeutic effects in
the simultaneous treatment of these infections.
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